Gilead Sciences Inc. faces renewed allegations it bought an API used in three of its HIV drugs from an unapproved Chinese supplier after a US Court of Appeals ruling.
A Californian appeals court ruling may have altered product liability in the state, which could lead to numerous court cases being brought against big pharma.
King Pharmaceuticals last week announced that it would be cutting
20 per cent of its workforce after the US Court of Appeals reversed
a previous court ruling and invalidated a patent covering the
firm's blood pressure drug, Altace...
Momenta, a US biotech company whose polysaccharide technology for
the delivery and improved formulation of existing drugs promises
lucrative revenues, is worried its generic version of
Sanofi-Aventis's Lovenox may be in jeopardy...